Cost-effectiveness analysis of paclitaxel and cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer. A European perspective (Q74450936)
Jump to navigation
Jump to search
scientific article published on 01 November 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness analysis of paclitaxel and cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer. A European perspective |
scientific article published on 01 November 1998 |
Statements
Cost-effectiveness analysis of paclitaxel and cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer. A European perspective (English)
T Fischer
1 November 1998